Physician profile
Haley M Wolf
NPI 1558994442
$3,673.14
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,522 · 2022: $151.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $1,200.00 | 2021 | |
| Viiv Healthcare Company | $654.42 | 2021-2022 | |
| Gilead Sciences, INC. | $508.99 | 2021 | |
| Abbvie INC. | $329.05 | 2021 | |
| Lilly USA, LLC | $209.58 | 2021 | |
| Novo Nordisk INC | $137.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.30 | 2021 | |
| Organon LLC | $101.46 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $90.99 | 2021 | |
| Antares Pharma, INC. | $79.43 | 2021 | |
| Theratechnologies INC. | $55.03 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $33.86 | 2021 | |
| Optinose US, INC. | $23.89 | 2021 | |
| Amarin Pharma, INC. | $21.85 | 2021 | |
| Janssen Pharmaceuticals, INC | $21.61 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.27 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.27 | 2021 | |
| Eisai INC. | $13.67 | 2021 | |
| Pfizer INC. | $11.38 | 2021 | |
| Dynavax Technologies Corporation | $7.90 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.